Old Web
English
Sign In
Acemap
>
authorDetail
>
Mark A. Johnson
Mark A. Johnson
Research Triangle Park
Medicine
Pharmacokinetics
Pharmacology
Cobicistat
Immunology
2
Papers
9
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase 1 Study to Assess the Relative Bioavailability, Food Effect, and Safety of a Tablet Formulation of GSK2838232, a Novel HIV Maturation Inhibitor in Healthy Participants After Single and Repeated Doses
2020
Clinical pharmacology in drug development
Mark A. Johnson
Roxanne C. Jewell
Jianjun Gan
Etienne Dumont
Olivia Burns
Brian A. Johns
Show All
Source
Cite
Save
Citations (1)
A Phase IIa Study Evaluating Safety, Pharmacokinetics, and Antiviral Activity of GSK2838232, a Novel, Second-generation Maturation Inhibitor, in Participants With Human Immunodeficiency Virus Type 1 Infection
2019
Clinical Infectious Diseases
Edwin DeJesus
Sara Duckworth Harward
Roxanne C. Jewell
Mark A. Johnson
Etienne Dumont
Viviana Wilches
Fiona C. Halliday
Christine L. Talarico
Jerry Jeffrey
Jianjun Gan
Jianfeng Xu
Franco Felizarta
Anita Scribner
Moti Ramgopal
Paul M. Benson
Brian A. Johns
Show All
Source
Cite
Save
Citations (8)
1